Here, we aimed to investigate the impact of viral stimuli, which are considered possible triggers of MAS, as well as IL-1 blocking therapies, potentially distorting an IL-1-T1IFN balance, on IL-18 expression and release as well as on hemophagocytosis. Here, IL1A is linked to macrophage activation syndrome.